Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11865081 Oncolytic viral delivery of therapeutic polypeptides

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 28, 2018
0
Date of Patent
January 9, 2024
0
Patent Application Number
16958371
0
Patent Citations
‌
US Patent 11078280 Oncolytic viral delivery of therapeutic polypeptides
0
‌
US Patent 10576115 Oncolytic HSV vector
0
‌
US Patent 10604574 Oncolytic viral delivery of therapeutic polypeptides
0
‌
US Patent 6984720 Human CTLA-4 antibodies
0
‌
US Patent 7056704 RNA interference mediating small RNA molecules
0
‌
US Patent 7078196 RNA interference mediating small RNA molecules
0
‌
US Patent 7109003 Methods for expressing and recovering human monoclonal antibodies to CTLA-4
0
‌
US Patent 7132281 Methods and host cells for producing human monoclonal antibodies to CTLA-4
0
‌
US Patent 7282564 RNA interference pathway genes as tools for targeted genetic interference
0
‌
US Patent 7432249 Oligoribonucleotides and ribonucleases for cleaving RNA
0
•••
Patent Inventor Names
Luke Evnin
0
Mitchell H. Finer
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11865081
0
Patent Primary Examiner
‌
Jane J Zara
0
CPC Code
‌
A61K 2039/505
0
‌
C07K 16/2809
0
‌
C07K 2317/31
0
‌
A61P 35/00
0

Find more entities like US Patent 11865081 Oncolytic viral delivery of therapeutic polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.